Changing the Default for Tobacco Treatment

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the impact and efficacy of a new approach to smoking cessation treatment versus the traditional approach.

Clinical Trial Description

In many health conditions, the default treatment approach is to first identify the health condition and then begin treatment. In this scenario, the physician discusses treatment options with the patient. The patient is free to decline treatment as they wish. If patients do nothing though, they will receive care. For tobacco users, the default treatment is for them to "opt in" to receive smoking cessation assistance. The provider asks the smoker if they are ready to quit, and they offer medication and support only to those who respond back "yes". This limits the amount of smokers that receive treatment because only 1 in 3 smokers say they are ready to quit. This study is looking at a novel approach to smoking cessation treatment. This study will compare the traditional, "standard of care" approach to opting in against a new approach where all smokers are provided with cessation medication and counseling unless they refuse it. ;

Study Design

Related Conditions & MeSH terms

Tobacco Use Cessation

Clinical Trial Details

NCT number	NCT02721082
Study type	Interventional
Source	University of Kansas Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	September 1, 2016
Completion date	December 9, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06021652` - Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening	N/A
Completed	`NCT02735382` - EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study	N/A
Completed	`NCT02557919` - Families Reduce Exposure to Smoke at Home	N/A
Completed	`NCT01570595` - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV	Phase 1/Phase 2
Completed	`NCT00786149` - Improving Varenicline Adherence and Outcomes in Homeless Smokers	Phase 3
Completed	`NCT00387946` - Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)	Phase 3
Completed	`NCT00218452` - Smoking Cessation for Young Adults Who Binge Drink - 1	Phase 0
Completed	`NCT00124683` - Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1	Phase 2
Recruiting	`NCT04610931` - Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation	N/A
Enrolling by invitation	`NCT06042361` - Enhancing Equity in Smoke-free Housing	N/A
Recruiting	`NCT04994444` - Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts	Phase 2/Phase 3
Recruiting	`NCT04827420` - Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)	N/A
Completed	`NCT05560243` - Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil	N/A
Completed	`NCT01885221` - A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)	N/A
Completed	`NCT03445507` - Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.	N/A
Completed	`NCT04540081` - Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer	N/A
Completed	`NCT03714191` - Optimizing the Tobacco Cessation Clinical Decision Support Tool.
Completed	`NCT03553992` - An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers	N/A
Completed	`NCT01699828` - Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET	Phase 1/Phase 2
Completed	`NCT01328431` - Treating Low-Income Smokers in the Hospital Emergency Department	N/A